#fragmentomics ผลการค้นหา

🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025! Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis. #gene #fragmentomics

CNAPS2025's tweet image. 🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025!

Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis.

#gene #fragmentomics

6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.

rtsundby's tweet image. 6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.

cfDNA fragmentomics is the category of histology formed by integrating the fragment characteristics of cfDNA. The #fragmentomics of #cfDNA holds promise for the noninvasive detection of tissue-specific diseases. 📚Cell-Free DNA Fragmentomics: The Novel Promising Biomarker


Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1. Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri @jack_shern @AngelaHirbe

rtsundby's tweet image. Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1.  Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri  @jack_shern @AngelaHirbe

DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.

FlorentMouliere's tweet image. DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.

Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…

FlorentMouliere's tweet image. Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation

MolOncology's tweet image. Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics

🔦 buff.ly/dsaLPGJ

#Fragmentomics #ctDNA #DNAmet #DNAmethylation

Join us as Dr. Umberto Malapelle explores the latest in tumor profiling, including #fragmentomics and methylation signatures in cfDNA. Learn more at #PrecisionInPractice on September 27th and 28th. Contact: [email protected]


We kept busy this summer investing in 3 more startups! First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round. Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.

medaangels's tweet image. We kept busy this summer investing in 3 more startups!  First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round.  Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.

🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️ Thanks @UmbertoMalapel1 for your constant vision 👇🏻futuremedicine.com/doi/10.2217/ep…

VGristina's tweet image. 🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️

Thanks @UmbertoMalapel1 for your constant vision 

👇🏻futuremedicine.com/doi/10.2217/ep…

✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025! Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer. #CNAPS #fragmentomics #liquidbiopsy

CNAPS2025's tweet image. ✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025!

Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer.

#CNAPS #fragmentomics #liquidbiopsy

How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl

ClaretBio's tweet image. How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl

Can #fragmentomics become a new monitoring #biomarker in metastatic breast cancer? 🔬 👉 Here we explore a mutation-agnostic, cost-effective approach tested in the MAGNETIC.1 trial—a longitudinal study of first-line HR+/HER2- MBC. doi.org/10.1016/j.tran…


Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower

DELFIDiagnostic's tweet image. Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower

Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…

ClaretBio's tweet image. Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…

Our paper in Cancer Discovery (@CD_AACR): A blood sample 🧪 can track #immunotherapy response & predict outcomes across cancer types using #ctDNA methylomes and #fragmentomics. No tumor tissue needed! aacrjournals.org/cancerdiscover… @PughLab @lillian_siu @UHN @pmcancercentre @UofTDRO


DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley bit.ly/40xzBOu #CancerResearch #Fragmentomics

DELFIDiagnostic's tweet image. DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.”

Feb 6, 9 am PT | Silicon Valley

bit.ly/40xzBOu

#CancerResearch #Fragmentomics

Later on, $GH brought in #fragmentomics via a combination of their own developments and acquisitions. The fragmentomics profiling of ctDNA is complementary to #methylation marks and adds up to better AUCs.


ไม่พบผลลัพธ์สำหรับ "#fragmentomics"

🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025! Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis. #gene #fragmentomics

CNAPS2025's tweet image. 🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025!

Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis.

#gene #fragmentomics

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation

MolOncology's tweet image. Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics

🔦 buff.ly/dsaLPGJ

#Fragmentomics #ctDNA #DNAmet #DNAmethylation

Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…

FlorentMouliere's tweet image. Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…

🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️ Thanks @UmbertoMalapel1 for your constant vision 👇🏻futuremedicine.com/doi/10.2217/ep…

VGristina's tweet image. 🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️

Thanks @UmbertoMalapel1 for your constant vision 

👇🏻futuremedicine.com/doi/10.2217/ep…

Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1. Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri @jack_shern @AngelaHirbe

rtsundby's tweet image. Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1.  Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri  @jack_shern @AngelaHirbe

6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.

rtsundby's tweet image. 6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.

DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.

FlorentMouliere's tweet image. DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.

We kept busy this summer investing in 3 more startups! First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round. Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.

medaangels's tweet image. We kept busy this summer investing in 3 more startups!  First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round.  Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.

How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl

ClaretBio's tweet image. How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl

✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025! Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer. #CNAPS #fragmentomics #liquidbiopsy

CNAPS2025's tweet image. ✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025!

Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer.

#CNAPS #fragmentomics #liquidbiopsy

Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower

DELFIDiagnostic's tweet image. Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower

Susan Tousi, CEO of Ilumina Ventures portfolio company @DELFIDiagnostic recently spoke with @Nasdaq to discuss #fragmentomics and its application in DELFI's blood-based FirstLook Test for enhancing #LungCancer screening. See the full interview here: nasdaq.com/videos/delfi-d…

illuminaventure's tweet image. Susan Tousi, CEO of Ilumina Ventures portfolio company @DELFIDiagnostic recently spoke with @Nasdaq to discuss #fragmentomics and its application in DELFI's blood-based FirstLook Test for enhancing #LungCancer screening. 

See the full interview here: nasdaq.com/videos/delfi-d…

Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…

ClaretBio's tweet image. Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…

DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley bit.ly/40xzBOu #CancerResearch #Fragmentomics

DELFIDiagnostic's tweet image. DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.”

Feb 6, 9 am PT | Silicon Valley

bit.ly/40xzBOu

#CancerResearch #Fragmentomics

Loading...

Something went wrong.


Something went wrong.


United States Trends